7/1/2025 2:00:08 PM The Buzz Around Femtech at New York Tech Week 2025 By Jennifer Yoo The femtech sector's evolution presents opportunities for tech, healthcare, and life sciences companies that are both vast and largely...
6/27/2025 5:54:25 PM Reassessing Irreparable Harm: Are Injunctions Making a Comeback? By Jon McMichael In an unusual move, the U.S. Department of Justice and U.S. Patent and Trademark Office submitted a “Statement of Interest” this week in...
6/26/2025 1:54:08 PM Brands May Need To Disclose The Use of AI Performers By Kimberly Culp The New York legislature recently passed a bill, A.8887-B(Rosenthal)/S.8420-A(Gianaris), that would mandate the conspicuous disclosure of...
6/25/2025 1:55:21 PM Buy-Side M&A Playbook: Drafting Definitive Agreements – The Road to Closing By Stephen Fisher Patrick Grilli David Hayes This article is part of Fenwick's "Buy-Side M&A Playbook" series, published as part of the Silicon Valley Defense Group's Industry...
6/20/2025 2:00:16 PM SEC News Roundup By David Bell Ran Ben-Tzur Amanda Rose Wendy Grasso +1 more... Show less Catch up on the latest SEC news, including agency guidance, tips, requests for input, and more. Petition for Rulemaking with Respect to...
6/19/2025 10:40:08 AM Senate Bill Would Augment QSBS Benefits for Startup Founders and Investors By William Skinner Kris Hatch The Senate Finance Committee's version of the Republicans' budget reconciliation legislation (the “Senate Bill”) would significantly...
6/18/2025 11:23:57 PM What Founders Actually Own at IPO (And Why It Matters Now More Than Ever) By Michael Esquivel Founders often dream about the IPO moment—the bell-ringing, the headlines, the validation. But what’s often overlooked is what ownership...
6/18/2025 2:00:05 PM FINRA Fee Cap Increase Coming in July By David Bell Ran Ben-Tzur Amanda Rose Wendy Grasso +1 more... Show less Some issuers will be subject to higher FINRA fee caps beginning July 1, 2025. Section 7 of Schedule A to the FINRA By-Laws sets forth the...
6/17/2025 10:01:11 PM Tax Court Says AbbVie's $1.6B Break Fee Payment to Shire Properly Deducted as Ordinary Expense By Vanessa Park-Thompson A break fee in a merger-gone-south can be deducted as an ordinary expense, the U.S. Tax Court held today, finding for biopharmaceutical...
6/16/2025 2:36:46 PM SEC Withdraws 2022 Proposed Amendment to Rule 14a-8 By David Bell Ran Ben-Tzur Amanda Rose Wendy Grasso +1 more... Show less On June 12, 2025, the SEC announced its withdrawal of previously proposed amendments to Rule 14a-8. The amendments, proposed in June...
6/16/2025 2:16:18 PM SEC Staff Says Certain Protocol Staking Activities Don't Constitute the Sale of Securities By David Bell Ran Ben-Tzur Amanda Rose Wendy Grasso +1 more... Show less The SEC’s Division of Corporation Finance recently issued a statement on Certain Protocol Staking Activities, essentially articulating...
6/13/2025 6:42:19 PM From AI to IP: What’s Shaping Biotech in 2025? By Rob Freedman Jon McMichael Chen Chen As BIO 2025 approaches in Boston, eight pivotal trends are emerging at the intersection of science, business, IP, and regulation:...